News & Press Releases

This feature article discuses key takeaways following Anthem’s $115 million settlement – one of the largest following a consumer data breach. Mintz Member Dianne Bourque is among the sources discussing what the health care industry can learn.

A team of Mintz attorneys - Mike Renaud, Rob Kidwell and Rob Moore - authored this issues response op-ed discussing the Department of Justice's (DOJ) statements on intellectual property rights, "the New Madison Approach." This approach marks a return to the core principles on which the patent laws are predicated.

This Law360 analysis piece looks at how the U.S. Food and Drug Administration (FDA) is easing concerns about off-label marketing restrictions without antagonizing the plaintiffs bar or public health advocates. FDA attorney Joanne Hawana is quoted providing third-party commentary in the piece.

This in-depth article looks at the hotly-contested and closely-watched patent battle between Qualcomm and Apple. The piece further discusses what potential legal decisions in 2019 could mean for the tech industry moving forward. Mintz Member Jim Wodarski is among the third-party sources quoted providing commentary throughout the piece.

Gil Samberg, a New York-based Mintz litigator, authored this Law360 "Expert Analysis" column discussing new rules from the Hong Kong International Arbitration Center which provide noteworthy institutional means for joinder of parties and consolidation of proceedings so as to effectuate collective or opt-in class arbitration proceedings.

This piece looks at what could make the proposed Making Objective Drug Evidence Revisions for New Modern Labeling (MODERN) Act stronger - primarily liability protection for generics. Joanne Hawana is among the FDA industry sources quoted providing commentary in the piece.